G. Papatheodoridis Et Al. , "Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy," JOURNAL OF HEPATOLOGY , vol.75, 2021
Papatheodoridis, G. Et Al. 2021. Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy. JOURNAL OF HEPATOLOGY , vol.75 .
Papatheodoridis, G., Dalekos, G., İDİLMAN, R., Sypsa, V., Buti, M., Calleja Panero, J. L., ... Goulis, I.(2021). Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy. JOURNAL OF HEPATOLOGY , vol.75.
Papatheodoridis, George Et Al. "Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy," JOURNAL OF HEPATOLOGY , vol.75, 2021
Papatheodoridis, George Et Al. "Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy." JOURNAL OF HEPATOLOGY , vol.75, 2021
Papatheodoridis, G. Et Al. (2021) . "Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy." JOURNAL OF HEPATOLOGY , vol.75.
@article{article, author={George Papatheodoridis Et Al. }, title={Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy}, journal={JOURNAL OF HEPATOLOGY}, year=2021}